These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38913308)

  • 1. Cancer Sample Analysis Utilizing Single-Nucleotide Polymorphism Array and Array Comparative Genomic Hybridization.
    Kang B; Xiao H; Ackley T; Shao L
    Methods Mol Biol; 2024; 2825():151-171. PubMed ID: 38913308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of previously cryptic copy number alterations and loss of heterozygosity in pediatric acute myeloid leukemia and myelodysplastic syndrome determined using combined array comparative genomic hybridization plus single-nucleotide polymorphism microarray analyses.
    Koh KN; Lee JO; Seo EJ; Lee SW; Suh JK; Im HJ; Seo JJ
    J Korean Med Sci; 2014 Jul; 29(7):926-33. PubMed ID: 25045224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Array-Based Comparative Genomic Hybridization (aCGH).
    Zhang C; Cerveira E; Romanovitch M; Zhu Q
    Methods Mol Biol; 2017; 1541():167-179. PubMed ID: 27910023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Density matters: comparison of array platforms for detection of copy-number variation and copy-neutral abnormalities.
    Mason-Suares H; Kim W; Grimmett L; Williams ES; Horner VL; Kunig D; Goldlust IS; Wu BL; Shen Y; Miller DT; Martin CL; Rudd MK
    Genet Med; 2013 Sep; 15(9):706-12. PubMed ID: 23558256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer.
    Staaf J; Jönsson G; Ringnér M; Baldetorp B; Borg A
    Breast Cancer Res; 2011; 13(6):R129. PubMed ID: 22169037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
    Ronaghy A; Yang RK; Khoury JD; Kanagal-Shamanna R
    Curr Hematol Malig Rep; 2020 Jun; 15(3):194-202. PubMed ID: 32382988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods.
    Xu X; Johnson EB; Leverton L; Arthur A; Watson Q; Chang FL; Raca G; Laffin JJ
    Cancer Genet; 2013; 206(9-10):317-26. PubMed ID: 24269304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
    Marescalco MS; Capizzi C; Condorelli DF; Barresi V
    J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility and limitation of single nucleotide polymorphism analysis on whole genome amplified mesenchymal tumour DNA in formalin fixed tumour samples.
    Liang CW; Lee YS; Marino-Enriquez A; Tsui K; Huang SH
    Pathology; 2012 Jan; 44(1):33-41. PubMed ID: 22157688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of copy number and loss of heterozygosity in primary breast carcinomas using high-density SNP array.
    Ching HC; Naidu R; Seong MK; Har YC; Taib NA
    Int J Oncol; 2011 Sep; 39(3):621-33. PubMed ID: 21687935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Utilization of Chromosomal Microarray Technologies for Hematologic Neoplasms: An ACLPS Critical Review.
    Peterson JF; Van Dyke DL; Hoppman NL; Kearney HM; Sukov WR; Greipp PT; Ketterling RP; Baughn LB
    Am J Clin Pathol; 2018 Oct; 150(5):375-384. PubMed ID: 30052716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
    Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
    Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.
    Toma MI; Grosser M; Herr A; Aust DE; Meye A; Hoefling C; Fuessel S; Wuttig D; Wirth MP; Baretton GB
    Neoplasia; 2008 Jul; 10(7):634-42. PubMed ID: 18592004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAFFYS: An Integrated Tool for Comprehensive Analysis of Genomic Aberrations in Tumor Samples.
    Liu Y; Li A; Feng H; Wang M
    PLoS One; 2015; 10(6):e0129835. PubMed ID: 26111017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNP arrays: comparing diagnostic yields for four platforms in children with developmental delay.
    D'Amours G; Langlois M; Mathonnet G; Fetni R; Nizard S; Srour M; Tihy F; Phillips MS; Michaud JL; Lemyre E
    BMC Med Genomics; 2014 Dec; 7():70. PubMed ID: 25539807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpreting aCGH-defined karyotypic changes in gliomas using copy number status, loss of heterozygosity and allelic ratios.
    Cowell JK; Lo KC; Luce J; Hawthorn L
    Exp Mol Pathol; 2010 Feb; 88(1):82-9. PubMed ID: 19818351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic differences between estrogen receptor (ER)-positive and ER-negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis.
    Fang M; Toher J; Morgan M; Davison J; Tannenbaum S; Claffey K
    Cancer; 2011 May; 117(10):2024-34. PubMed ID: 21523713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated analysis tool for analyzing hybridization intensities and genotypes using new-generation population-optimized human arrays.
    Huang MC; Chuang TP; Chen CH; Wu JY; Chen YT; Li LH; Yang HC
    BMC Genomics; 2016 Mar; 17():266. PubMed ID: 27029637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.